Literature DB >> 33658124

How to overcome the side effects of tumor immunotherapy.

Shang Li1, Zhibi Zhang2, Wing-Fu Lai3, Liao Cui4, Xiao Zhu5.   

Abstract

The incidence of cancer is increasing year by year. Cancer has become one of the health threats of modern people. Simply relying on the surgery, chemotherapy or radiotherapy, not only the survival rate is not high, but also the quality of life of patients is not much better. Fortunately, the emergence and rapid development of cancer immunotherapy have brought more and more exciting results. However, when scientists think it is possible to overcome cancer, they find that not all cancer patients can benefit from immunotherapy, that is to say, the overall efficiency of immunotherapy is not high. Drug resistance and side effects of immunotherapy cannot be ignored. In order to overcome these difficulties, scientists continue to improve the strategy of immunotherapy and find that combination therapy can effectively reduce the incidence of drug resistance. They also found that by reprogramming tumor blood vessels, activating ferroptosis, utilizing thioredoxin, FATP2 and other substances, the therapeutic effect can be improved and side effects can be alleviated. This article reviews the principles of immunotherapy, new strategies to overcome drug resistance of cancer immunotherapy, and how to improve the efficacy of immunotherapy and reduce side effects.
Copyright © 2020 The Author(s). Published by Elsevier Masson SAS.. All rights reserved.

Entities:  

Keywords:  Immunotherapy; New strategies; Resistance; Side effects

Year:  2020        PMID: 33658124     DOI: 10.1016/j.biopha.2020.110639

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  12 in total

Review 1.  Development of Anticancer Peptides Using Artificial Intelligence and Combinational Therapy for Cancer Therapeutics.

Authors:  Ji Su Hwang; Seok Gi Kim; Tae Hwan Shin; Yong Eun Jang; Do Hyeon Kwon; Gwang Lee
Journal:  Pharmaceutics       Date:  2022-05-06       Impact factor: 6.525

2.  Cell subtypes and immune dysfunction in peritoneal fluid of endometriosis revealed by single-cell RNA-sequencing.

Authors:  Gen Zou; Jianzhang Wang; Xinxin Xu; Ping Xu; Libo Zhu; Qin Yu; Yangying Peng; Xinyue Guo; Tiantian Li; Xinmei Zhang
Journal:  Cell Biosci       Date:  2021-05-26       Impact factor: 7.133

3.  Clinical and Prognostic Pan-Cancer Analysis of N6-Methyladenosine Regulators in Two Types of Hematological Malignancies: A Retrospective Study Based on TCGA and GTEx Databases.

Authors:  Xiangsheng Zhang; Liye Zhong; Zhilin Zou; Guosheng Liang; Zhenye Tang; Kai Li; Shuzhen Tan; Yongmei Huang; Xiao Zhu
Journal:  Front Oncol       Date:  2021-03-18       Impact factor: 6.244

4.  A SIRPαFc Fusion Protein Conjugated With the Collagen-Binding Domain for Targeted Immunotherapy of Non-Small Cell Lung Cancer.

Authors:  Jiayang Liu; Zhefeng Meng; Tongyang Xu; Kudelaidi Kuerban; Songna Wang; Xuyao Zhang; Jiajun Fan; Dianwen Ju; Wenzhi Tian; Xuan Huang; Xiting Huang; Danjie Pan; Huaning Chen; Weili Zhao; Li Ye
Journal:  Front Immunol       Date:  2022-03-29       Impact factor: 7.561

Review 5.  Role of STK11 in ALK-positive non-small cell lung cancer.

Authors:  Wen Zhou; Lu-Da Yan; Zhi-Qiong Yu; Na Li; Yong-Hua Yang; Meng Wang; Yuan-Yuan Chen; Meng-Xia Mao; Xiao-Chun Peng; Jun Cai
Journal:  Oncol Lett       Date:  2022-04-15       Impact factor: 2.967

6.  Identified Gefitinib Metabolism-Related lncRNAs can be Applied to Predict Prognosis, Tumor Microenvironment, and Drug Sensitivity in Non-Small Cell Lung Cancer.

Authors:  Weilong Ye; Zhengguo Wu; Pengbo Gao; Jianhao Kang; Yue Xu; Chuzhong Wei; Ming Zhang; Xiao Zhu
Journal:  Front Oncol       Date:  2022-07-01       Impact factor: 5.738

7.  Spinal epidural abscess in COVID-19 patients.

Authors:  G Talamonti; Davide Colistra; Francesco Crisà; Marco Cenzato; Pietro Giorgi; Giuseppe D'Aliberti
Journal:  J Neurol       Date:  2020-09-10       Impact factor: 4.849

Review 8.  Smart Lipid-Based Nanosystems for Therapeutic Immune Induction against Cancers: Perspectives and Outlooks.

Authors:  Seth-Frerich Fobian; Ziyun Cheng; Timo L M Ten Hagen
Journal:  Pharmaceutics       Date:  2021-12-23       Impact factor: 6.321

Review 9.  Recent Advances in Polymer Additive Engineering for Diagnostic and Therapeutic Hydrogels.

Authors:  Sang-Wook Bae; Jiyun Kim; Sunghoon Kwon
Journal:  Int J Mol Sci       Date:  2022-03-09       Impact factor: 5.923

Review 10.  Mesenchymal stem cells: ideal seeds for treating diseases.

Authors:  Guanwen Gao; Chenyang Fan; Weiquan Li; Runzhang Liang; Chuzhong Wei; Xiaojie Chen; Yue Yang; Yueyuan Zhong; Yingqi Shao; Yi Kong; Zesong Li; Xiao Zhu
Journal:  Hum Cell       Date:  2021-07-16       Impact factor: 4.374

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.